• Injective integrates Mountain Protocol, introducing USDM stablecoin with a 5% annual yield.
• Ondo Finance and Injective collaboration boost capital efficiency in Injective dApps.

In a tweet, analyst Captain Faibik stated that Injective (INJ) has had a Falling Wedge upward breakout and retest verified on the 3-day time frame chart. This pattern appears to be quite bullish for the midterms. Faibik wants to see the token reach a new high, above $65.

Despite the recent fall in the crypto market, which followed the US government’s large $2 billion BTC transfer, Faibik has found some intriguing assets, such as Injective, that have the potential to rise.

INJ Faces Short-Term Decline but Gains Long-Term Optimism with USDM Integration 

INJ is currently trading around $24.49, down 3.03% over the last 24 hours and consolidating over the past week. Despite the unpredictability, Faibik remains optimistic.

Previously, CNF revealed that Injective has integrated the Mountain Protocol and introduced USDM, a native yield-bearing stablecoin backed by Treasury bills. USDM provides a 5% annual income, enabling a variety of real-world asset use cases inside the Injective ecosystem.

Furthermore, Ondo Finance has collaborated with Injective, offering the USDY token to improve capital efficiency in Injective dApps. As we previously reported, Injective is expediting the use of tokenized assets by introducing the world’s first RWA module that supports FX, commodities, and more.

This strategic move establishes Injective as a market leader in tokenization, with the goal of connecting traditional financial assets to the booming cryptocurrency sector.

In addition to these relationships, Injective has been acknowledged for its revolutionary Layer-1 solutions, which promise to enable faster and more efficient blockchain transactions.

Injective’s commitment to developing a more smooth and scalable blockchain infrastructure is a critical aspect that could fuel its long-term success.